ASHLEY ATKINSON: Open Payments
NPI 1578003133 · MARTINEZ, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 68 payments from 14 companies in 2025. Trend: 2023 $1,075 · 2024 $1,171 · 2025 $1,219
Food & beverage: $1,174Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $471 |
| Lilly USA, LLC | 19 | $213 |
| AstraZeneca Pharmaceuticals LP | 4 | $142 |
| Exact Sciences Corporation | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Boston Scientific Corporation | 1 | $38 |
| PFIZER INC. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Ozempic, Wegovy, MOUNJARO, BREZTRI, Cologuard Collection Kit, VOQUEZNA, ZEPBOUND, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
